A detailed history of Rothschild Investment LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 40 shares of SAVA stock, worth $1,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 15 166.67%
Holding current value
$1,059
Previous $185,000 536.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$9.57 - $35.08 $239 - $877
25 Added 166.67%
40 $1.18 Million
Q2 2024

Jul 30, 2024

BUY
$12.35 - $26.11 $185 - $391
15 New
15 $185,000
Q1 2024

Jul 31, 2024

SELL
$18.44 - $26.41 $184 - $264
-10 Reduced 66.67%
5 $101,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.06B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.